Table 1.
Baseline Characteristics of the Study Cohort
| Characteristic | Value (n = 78) |
|---|---|
| Demographics | |
| Age (yr) | 17.2 ± 8.7 |
| Female sex | 35 (44.9) |
| Saudi nationality | 64 (82.0) |
| Comorbidities | |
| Diabetes mellitus | 1 (1.3) |
| Hypertension | 1 (1.3) |
| Family history | |
| Family history of IBD | 5 (6.4) |
| History of parental consanguinity | 18 (23.0) |
| Presenting symptoms | |
| Diarrhea | 56 (72.0) |
| Abdominal pain | 51 (65.4) |
| Weight loss | 44 (56.4) |
| Fatigue | 39 (50.0) |
| Vomiting | 21 (26.9) |
| Dysphagia | 2 (2.6) |
| Montreal classification | |
| Age group | |
| A1 (< 17 yr) | 44 (56.4) |
| A2 (17–40 yr) | 31 (39.7) |
| A3 (> 40 yr) | 3 (3.8) |
| Location | |
| L1 (Terminal ileal) | 28 (35.9) |
| L2 (Colonic) | 26 (33.3) |
| L3 (Ileo-colonic) | 24 (30.8) |
| Behavior | |
| B1 (Non-stricturing, non-penetrating) | 68 (87.2) |
| B2 (Stricturing) | 7 (9.0) |
| B3 (Penetrating) | 3 (3.8) |
| Extraintestinal manifestations | |
| Aphthous stomatitis | 8 (10.3) |
| Perianal disease | 8 (10.3) |
| Eye inflammation | 3 (3.8) |
| Complications of CD | 24 (30.8) |
| Laboratory investigations | |
| Leukocyte count (× 103/μL) | 9.0 ± 3.1 |
| Hemoglobin (g/dL) | 10.1 ± 3.1 |
| Platelets (× 103/μL) | 507.6 ± 164.3 |
| Albumin (g/L) | 26.0 ± 7.7 |
| CRP (mg/L) | 49.5 ± 42.0 |
Values are presented as mean±SD or number (%).